Lumos Labs

Lumos Labs is a San Francisco-based neurotechnology company operating at the intersection of cognitive science and digital health. The company is best known for Lumosity, a brain training platform that delivers a suite of games and exercises scientifically designed to challenge core cognitive domains including memory, attention, cognitive flexibility, speed of processing, and problem-solving. Lumosity's underlying technology leverages adaptive algorithms that adjust task difficulty in real time based on individual user performance, creating personalized training experiences at scale. The platform is accessible across web and mobile environments, making it one of the most widely distributed cognitive health tools available to consumers today.

Lumos Labs has grown Lumosity into one of the largest brain training platforms in the world, amassing a user base exceeding 100 million registered users across more than 180 countries. The company has raised $67 million in funding through a Series D round, reflecting sustained investor confidence in the cognitive health market. Beyond its consumer product, Lumosity has established a research infrastructure that enables collaboration with academic and institutional partners to study cognitive performance, aging, and the effects of digital training interventions. These research initiatives have contributed to a growing body of published work examining how targeted cognitive exercises may influence mental performance across different population groups.

Lumos Labs represents a significant force in the broader neurotechnology industry by demonstrating that scalable, data-driven cognitive health tools can reach mainstream audiences while simultaneously advancing scientific understanding of the brain. At a time when cognitive decline, mental fitness, and brain health are rising priorities in both healthcare and consumer wellness markets, the company occupies a unique position bridging entertainment, behavioral science, and clinical research. The rich dataset generated by hundreds of millions of training sessions positions Lumos Labs as a valuable contributor to longitudinal research on human cognition. As the neurotech sector continues to mature, companies like Lumos Labs that combine consumer scale with scientific credibility will play an increasingly important role in shaping how the industry approaches preventive cognitive care.